Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow disease to deliver patient outcomes. Co. classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic candidates help healthcare professionals (HCPs) find, fight, and follow cancer, with a focus in prostate cancer. Its pipeline also includes breast and other cancers. Its Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. We show 39 historical shares outstanding datapoints in our LNTH shares outstanding history coverage, used to compute LNTH market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing LNTH market cap history over the course of time is important for investors
interested in comparing LNTH's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of LNTH versus a peer is one thing; comparing
LNTH market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like LNTH can fluctuate over the course of history.
With this page we aim to empower investors researching LNTH by allowing them to research the LNTH market cap history. |
Free LNTH Email Alerts:
Video: The Importance of Market Cap
